Alpha emitters are radionuclides having pharmacological action for cancer treatment. In preclinical and clinical trials of oncology studies, when these emitters are combined with monoclonal antibodies or nanoparticles have shown good cytotoxic results in oncology.
MARKET DYNAMICS
The Alpha Emitters market is driving due to increasing prevalence of cancer, the growing awareness aboit the use of alpha emitters in targeted therapies. Additionally, improved healthcare facilities in developed economies is also expected to boost market growth. However, the unfavorable regulations with use of alpha emitters is expected to restrain the growth of market.
MARKET SCOPE
The "Alpha Emitters Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of alpha emitters market with detailed market segmentation by type of radionuclide and application. The alpha emitters market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in alpha emitters market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The alpha emitters market is segmented on the basis of type of radionuclide and application. On the basis of type of radionuclide, the market is segmented as, Astatine (At-211), Radium (Ra-223), Actinium (Ac-225),Lead (Pb-212), Bismuth (Bi-212) and others . On the basis of application the market is segmented as Prostate Cancer, Bone Metastasis, Ovarian Cancer, Pancreatic Cancer Endocrine Tumors, Other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Alpha Emitters market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Alpha Emitters market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Alpha Emitters market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Alpha Emitters market in these regions.
MARKET PLAYERS
The report covers key developments in the Alpha Emitters market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Alpha Emitters market are anticipated to have lucrative growth opportunities in the future with the rising demand for Alpha Emitters in the global market. Below mentioned is the list of few companies engaged in the Alpha Emitters market.
The report also includes the profiles of key players in alpha emitters market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Actinium Pharmaceutical Inc.
- Alpha Tau Medical Ltd
- Bayer AG
- Fusion Pharmaceuticals
- IBA Radiopharma Solutions
- RadioMedix Inc.
- Telix Pharmaceuticals Ltd
- Global Medical Solutions
- SHINE Medical Technologies
- Isotopia Molecular Imaging Limited
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.